AAAAAA
Results:
1-7
|
Results: 7
Authors:
Salahshor, S
Lei, HX
Huo, HG
Kristensen, VN
Loman, N
Sjoberg-Margolin, S
Borg, A
Borresen-Dale, AL
Vorechovsky, I
Lindblom, A
Citation: S. Salahshor et al., Low frequency of E-cadherin alterations in familial breast cancer, BREAST CA R, 3(3), 2001, pp. 199-207
Authors:
Kristensen, VN
Kure, EH
Erikstein, B
Harada, N
Borresen-Dale, AL
Citation: Vn. Kristensen et al., Genetic susceptibility and environmental estrogen-like compounds, MUT RES-F M, 482(1-2), 2001, pp. 77-82
Authors:
Kristensen, VN
Kelefiotis, D
Kristensen, T
Borresen-Dale, AL
Citation: Vn. Kristensen et al., High-throughput methods for detection of genetic variation, BIOTECHNIQU, 30(2), 2001, pp. 318
Authors:
Kristensen, VN
Borresen-Dale, AL
Citation: Vn. Kristensen et Al. Borresen-dale, Molecular epidemiology of breast cancer: genetic variation in steroid hormone metabolism, MUT RES-R M, 462(2-3), 2000, pp. 323-333
Authors:
Kristensen, VN
Harada, N
Yoshimura, N
Haraldsen, E
Lonning, P
Erikstein, B
Karesen, R
Kristensen, T
Borresen-Dale, AL
Citation: Vn. Kristensen et al., Genetic variants of CYP19 (aromatase) and breast cancer risk, ONCOGENE, 19(10), 2000, pp. 1329-1333
Authors:
Kristensen, VN
Andersen, TI
Erikstein, B
Geitvik, G
Skovlund, E
Nesland, JM
Borresen-Dale, AL
Citation: Vn. Kristensen et al., Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients (vol 8, pg 441, 1998), PHARMACOGEN, 9(1), 1999, pp. 129-129
Authors:
Kristensen, VN
Haraldsen, EK
Anderson, KB
Lonning, PE
Erikstein, B
Karesen, R
Gabrielsen, OS
Borresen-Dale, AL
Citation: Vn. Kristensen et al., CYP17 and breast cancer risk: The polymorphism in the 5 ' flanking area ofthe gene does not influence binding to Sp-1, CANCER RES, 59(12), 1999, pp. 2825-2828
Risultati:
1-7
|